Gleason Group, Inc. Eli Lilly & CO Transaction History

Gleason Group, Inc.

$492 Million
Q2 2024

A detailed history of Gleason Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Gleason Group, Inc. holds 2,248 shares of LLY stock, worth $2.14 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

2,248

Previous 2,245 0.13%

Holding current value

$2.14 Million

Previous $1.75 Million 16.55%

% of portfolio

0.41%

Previous 0.37%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$724.87 - $909.04 $2,174 - $2,727	3 Added 0.13%	2,248 $2.04 Million
Q1 2024 Apr 12, 2024	BUY	$592.2 - $792.28 $1,184 - $1,584	2 Added 0.09%	2,245 $1.75 Million
Q4 2023 Jan 19, 2024	SELL	$525.19 - $619.13 $21,007 - $24,765	-40 Reduced 1.75%	2,243 $1.31 Million
Q3 2023 Oct 12, 2023	BUY	$434.7 - $599.3 $2,173 - $2,996	5 Added 0.22%	2,283 $1.23 Million
Q2 2023 Jul 20, 2023	BUY	$350.74 - $468.98 $1,753 - $2,344	5 Added 0.22%	2,278 $1.07 Million
Q1 2023 Apr 14, 2023	BUY	$310.63 - $364.82 $102,818 - $120,755	331 Added 17.04%	2,273 $780,000
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $1,929 - $2,248	6 Added 0.31%	1,942 $0
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $1,778 - $2,027	6 Added 0.31%	1,936 $626,000
Q2 2022 Jul 13, 2022	BUY	$278.73 - $327.27 $1,672 - $1,963	6 Added 0.31%	1,930 $626,000
Q1 2022 Apr 22, 2022	BUY	$234.69 - $291.66 $1,642 - $2,041	7 Added 0.37%	1,924 $551,000
Q4 2021 Jan 18, 2022	BUY	$224.85 - $279.04 $1,573 - $1,953	7 Added 0.37%	1,917 $530,000
Q3 2021 Oct 12, 2021	BUY	$221.6 - $272.71 $1,329 - $1,636	6 Added 0.32%	1,910 $441,000
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $1,444 - $1,868	8 Added 0.42%	1,904 $437,000
Q1 2021 Apr 14, 2021	BUY	$164.32 - $212.72 $1,150 - $1,489	7 Added 0.37%	1,896 $354,000
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $77,493 - $102,542	-594 Reduced 23.92%	1,889 $319,000
Q3 2020 Oct 15, 2020	SELL	$146.22 - $169.13 $30,121 - $34,840	-206 Reduced 7.66%	2,483 $368,000
Q2 2020 Aug 27, 2020	SELL	$136.42 - $164.18 $11,868 - $14,283	-87 Reduced 3.13%	2,689 $441,000
Q1 2020 Aug 27, 2020	SELL	$119.05 - $147.35 $4,166 - $5,157	-35 Reduced 1.25%	2,776 $385,000
Q4 2019 Aug 27, 2020	BUY	$106.92 - $132.43 $300,552 - $372,260	2,811 New	2,811 $369,000

Others Institutions Holding LLY

# of Institutions

3,857

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $903B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gleason Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gleason Group, Inc. with notifications on news.

Account

Gleason Group, Inc. Eli Lilly & CO Transaction History